Integrated Filing-Governance



General information about company

Scrip Code 543271
NSE Symbol JUBLINGREA
MSEI Symbol NOTLISTED
ISIN INE0BY001018
Name of the entity JUBILANT INGREVIA LIMITED
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Reporting Quarter Yearly
Date of Quarter Ending 31-Mar-2026
Type of company Equity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity? Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity? Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity? Yes
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity? No
Reason For Part D Of Annexure I Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity No fines or penalty was imposed on company during the quarter
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity? Yes
Whether Annexure I (Part F) of the SEBI Circular dated December 31, 2024 related to Disclosure Of Loans / Guarantees / Comfort Letters / Securities Etc. is Applicable to the entity? No
Reason For Part F Of Annexure I Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity No such instance occured during the quarter
Risk management committee Yes
Market Capitalisation as per immediate previous Financial Year Top 500 listed entities
Is SCORE ID Available ? Yes
SCORE Registration ID comJ00388
Reason For No SCORE ID
Type of Submission New
Remarks (website dissemination)



Annexure I
Annexure I to be submitted by listed entity on quarterly basis
I. Composition of Board of Directors
Disclosure of notes on composition of board of directors explanatory
Whether the listed entity has a Regular Chairperson Yes
Whether Chairperson is related to MD or CEO No Disqualification of Directors under section 164 of the Companies Act, 2013
Sr Title (Mr / Ms) Name of the Director PAN DIN Category 1 of directors Category 2 of directors Category 3 of directors Date of Birth Whether the director is disqualified? Start Date of disqualification End Date of disqualification Details of disqualification Current status Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations] Date of passing special resolution Initial Date of appointment Date of Re-appointment Date of cessation Tenure of director (in months) No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations) No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & 17A(2)] Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations) No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations) Reason for Cessation Notes for not providing PAN Notes for not providing DIN
1 Mr. SHYAM SUNDER BHARTIA 00010484 Non-Executive - Non Independent Director Chairperson 09-Nov-1952 No Active NA 06-Feb-2021 4 0 0 0
2 Mr. HARI SHANKER BHARTIA 00010499 Executive Director Not Applicable 12-Dec-1956 No Active NA 06-Feb-2021 01-Jun-2023 6 3 2 0
3 Mrs. SUDHA PILLAI 02263950 Non-Executive - Independent Director Not Applicable 01-May-1950 No Active Yes 30-Aug-2024 06-Feb-2021 06-Feb-2026 61.23 3 3 1 1
4 Mr. SUSHIL KUMAR ROONGTA 00309302 Non-Executive - Independent Director Not Applicable 09-May-1950 No Active Yes 30-Aug-2024 06-Feb-2021 06-Feb-2026 61.23 6 6 7 1
5 Mr. ARUN SETH 00204434 Non-Executive - Independent Director Not Applicable 19-Nov-1951 No Active Yes 29-Aug-2024 06-Feb-2021 06-Feb-2026 61.23 4 4 10 5
6 Mr. PRADEEP JYOTI BANERJEE 02985965 Non-Executive - Independent Director Not Applicable 19-Oct-1958 No Active NA 06-Feb-2021 06-Feb-2026 61.23 4 4 5 1
7 Mr. SIRAJ AZMAT CHOUDHARY 00161853 Non-Executive - Independent Director Not Applicable 08-Jan-1967 No Active NA 06-Feb-2021 06-Feb-2026 61.23 3 3 7 3
8 Mrs. AMEETA CHATTERJEE 03010772 Non-Executive - Independent Director Not Applicable 27-Dec-1972 No Active NA 17-Apr-2021 17-Apr-2021 59.14 2 2 2 0
9 Mr. PRIYAVRAT BHARTIA 00020603 Non-Executive - Non Independent Director Not Applicable 04-Oct-1976 No Active NA 06-Feb-2021 6 0 4 0
10 Mr. VIJAY KUMAR SRIVASTAVA 07381359 Executive Director Not Applicable 12-Apr-1976 No Active NA 01-Nov-2024 01-Nov-2024 1 0 0 0
11 Mr. DEEPAK JAIN 10255429 Executive Director Not Applicable CEO-MD 23-Jan-1981 No Active NA 01-Oct-2023 01-Oct-2023 1 0 1 0
12 Mrs. Aashti Bhartia 02840983 Non-Executive - Non Independent Director Not Applicable 21-Aug-1983 No Active NA 01-Aug-2025 2 0 1 0



Annexure 1

II. Composition of Committees
Disclosure of notes on composition of committees explanatory



Audit Committee Details
Whether the Audit Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00309302 SUSHIL KUMAR ROONGTA Non-Executive - Independent Director Chairperson 06-Feb-2021
2 00204434 ARUN SETH Non-Executive - Independent Director Member 06-Feb-2021
3 02985965 PRADEEP JYOTI BANERJEE Non-Executive - Independent Director Member 06-Feb-2021
4 00161853 SIRAJ AZMAT CHOUDHARY Non-Executive - Independent Director Member 06-Feb-2021
5 03010772 AMEETA CHATTERJEE Non-Executive - Independent Director Member 01-Feb-2022



Nomination and remuneration committee
Whether the Nomination and remuneration committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 02985965 PRADEEP JYOTI BANERJEE Non-Executive - Independent Director Chairperson 06-Feb-2021
2 00010484 SHYAM SUNDER BHARTIA Non-Executive - Non Independent Director Member 06-Feb-2021
3 02263950 SUDHA PILLAI Non-Executive - Independent Director Member 06-Feb-2021
4 00161853 SIRAJ AZMAT CHOUDHARY Non-Executive - Independent Director Member 06-Feb-2021
5 03010772 AMEETA CHATTERJEE Non-Executive - Independent Director Member 20-Dec-2021



Stakeholders Relationship Committee
Whether the Stakeholders Relationship Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00161853 SIRAJ AZMAT CHOUDHARY Non-Executive - Independent Director Chairperson 06-Feb-2021
2 00309302 SUSHIL KUMAR ROONGTA Non-Executive - Independent Director Member 06-Feb-2021
3 00204434 ARUN SETH Non-Executive - Independent Director Member 06-Feb-2021
4 10255429 DEEPAK JAIN Executive Director Member 07-Oct-2023



Risk Management Committee
Whether the Risk Management Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00204434 ARUN SETH ID Chairperson 06-Feb-2021
2 02263950 SUDHA PILLAI ID Member 06-Feb-2021
3 00309302 SUSHIL KUMAR ROONGTA ID Member 06-Feb-2021
4 02985965 PRADEEP JYOTI BANERJEE ID Member 06-Feb-2021
5 00161853 SIRAJ AZMAT CHOUDHARY ID Member 06-Feb-2021
6 03010772 AMEETA CHATTERJEE ID Member 01-Feb-2022
7 00020603 PRIYAVRAT BHARTIA NED Member 01-Feb-2022
8 02840983 Aashti Bhartia NED Member 01-Aug-2025
9 10255429 DEEPAK JAIN ED Member 07-Oct-2023
10 10774805 Varun Gupta CFO Member 22-Oct-2024 Textual Information(1)



Text Block
Textual Information(1) Appointment effective from October 22, 2024



Annexure 1
III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory
Sr Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Notes for not providing Date Whether requirement of Quorum met (Yes/No) Total Number of Directors as on date of the meeting Number of Directors present* (All directors including Independent Director) No. of Independent Directors attending the meeting*
1 27-Oct-2025 Yes 12 12 6
2 04-Feb-2026 99 Yes 12 12 6



Annexure 1
IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory
Sr Name of Committee Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Name of other committee Reson for not providing date Whether requirement of Quorum met (Yes/No) Total Number of Directors in the Committee as on date of the meeting Number of Directors Present (All Directors including Independent Director) No. of Independent Directors attending the meeting* No. of members attending the meeting (other than Board of Directors)
1 Audit Committee 27-Oct-2025 Yes 5 5 5 0
2 Nomination and remuneration committee 27-Oct-2025 Yes 5 5 4 0
3 Risk Management Committee 27-Oct-2025 Yes 10 9 6 1
4 Audit Committee 03-Feb-2026 98 Yes 5 5 5 0
5 Nomination and remuneration committee 04-Feb-2026 Yes 5 5 4 0



Annexure 1
VI. Affirmations
Sr Subject Compliance status (Yes/No)
1 The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
2 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee Yes
3 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee Yes
4 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee Yes
5 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities) Yes
6 The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. Yes
7 The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
8 This report and/or the report submitted in the previous quarter has been placed before Board of Directors. Yes
9 Any comments/observations/advice of Board of Directors may be mentioned here:



Annexure 1
Sr Subject Compliance status
1 Name of signatory Deepanjali Gulati
2 Designation Company Secretary and Compliance Officer



Details of Cyber security incidence
Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter No
Other details of cyber security incidence or breaches or loss of data event
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr Date of the event Brief details of the event



Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)
I. Disclosure on website in terms of LODR Regulation
Sr Item Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here. Web address
1.1 Details of business Yes https://www.jubilantingrevia.com/about-us/overview
1.2 Memorandum of Association and Articles of Association Yes https://www.jubilantingrevia.com/Uploads/image/1203imguf_memorandum-and-articles-of-association.pdf
1.3 Brief profile of board of directors including directorship and full time positions in body corporates Yes https://www.jubilantingrevia.com/about-us/board-of-directors
2 Terms and conditions of appointment of independent directors Yes https://www.jubilantingrevia.com/Uploads/image/407imguf_tc-appointmentofIndependentDirectors.pdf
3 Composition of various committees of board of directors Yes https://www.jubilantingrevia.com/Uploads/image/936imguf_composition-of-various-committees-bod.pdf
4 Code of conduct of board of directors and senior management personnel Yes https://www.jubilantingrevia.com/investors/corporate-governance/policies-and-codes/code-of-conduct
5 Details of establishment of vigil mechanism or whistle blower policy Yes https://www.jubilantingrevia.com/investors/corporate-governance/policies-and-codes/whistle-blower-policy
6 Criteria of making payments to non-executive directors Yes https://www.jubilantingrevia.com/Uploads/image/421imguf_CriteriaofmakingpaymentstoNon-ExecutiveDirectors.pdf
7 Policy on dealing with related party transactions Yes https://www.jubilantingrevia.com/investors/corporate-governance/policies-and-codes/policy-on-rpts
8 Policy for determining material subsidiaries Yes https://www.jubilantingrevia.com/investors/corporate-governance/policies-and-codes/policy-for-determining-material-subsidiaries
9 Details of familiarization programmes imparted to independent directors Yes https://www.jubilantingrevia.com/investors/corporate-governance/policies-and-codes/familiarisation-programme-for-independent-directors
10 Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances Yes https://www.jubilantingrevia.com/investors/investor-contact/nodal-officer
11 Email address for grievance redressal and other relevant details Yes https://www.jubilantingrevia.com/investors/investor-contact/investor-grievances
12 Financial results Yes https://www.jubilantingrevia.com/investors/financials/quarterly-results
13 Shareholding pattern Yes https://www.jubilantingrevia.com/investors/investor-information/share-holding-pattern
14 Details of agreements entered into with the media companies and/or their associates NA
15.1 Schedule of analyst or institutional investor meet and presentation prepared by listed entity for analyst or institutional investor meet Yes https://www.jubilantingrevia.com/investors/disclosure/schedule-of-analysts-institutional-investors-meet-presentations
15.2 Audio or video recordings and transcripts of post earnings/quarterly calls Yes https://www.jubilantingrevia.com/investors/disclosure/schedule-of-analysts-institutional-investors-meet-presentations
16 New name and the old name of the listed entity Yes https://www.jubilantingrevia.com/investors/investor-information/change-of-name
17 Advertisements as per regulation 47 (1) Yes https://www.jubilantingrevia.com/investors/intimation-to-stock-exchanges
18 Credit rating or revision in credit rating obtained Yes chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.jubilantingrevia.com/pdf/Credit-ratings.pdf
19 Separate audited financial statements of each subsidiary of the listed entity Yes https://www.jubilantingrevia.com/investors/financials/subsidiaries-accounts
20 Secretarial compliance report Yes https://www.jubilantingrevia.com/investors/disclosure/annual-secretarial-compliance-report
21 Materiality policy as per regulation 30 (4) Yes https://www.jubilantingrevia.com/investors/corporate-governance/policies-and-codes/policy-for-determination-of-materiality-of-events-and-information
22 Disclosure of contact details of KMP who are authorized for the purpose of determining materiality as required under regulation 30(5) Yes https://www.jubilantingrevia.com/Uploads/image/420imguf_KeyManagerialPersonnelforDeterminingMateriality.pdf
23 Disclosures under regulation 30(8) Yes https://www.jubilantingrevia.com/investors/disclosure/disclosure-under-30-8
24 Statements of deviation(s) or variations(s) as specified in regulation 32 NA
25 Dividend distribution policy as specified in regulation 43A (1) Yes https://www.jubilantingrevia.com/investors/corporate-governance/policies-and-codes/dividend-distribution-policy
26.1 Annual return as provided under section 92 of the Companies Act 2013 Yes https://www.jubilantingrevia.com/investors/disclosure
26.2 Employee benefit scheme documents framed in terms of SEBI (SBEB) regulations 2021
27 Confirmation that the above disclosures are in a separate section as specified in regulation 46(2) Yes https://www.jubilantingrevia.com/investors/disclosure
28 Compliance with regulation 46(3) with respect to accuracy of disclosures on the website and timely updation Yes https://www.jubilantingrevia.com/investors/disclosure
29 Disclosure of notes on website in terms of Listing Regulations explanatory


Annexure II
II. Annual Affirmations
Sr Particulars Regulation Number Compliance status (Yes/No/NA) If status is No details of non-compliance may be given here.
1 Independent director(s) have been appointed in terms of specified criteria of independence and/or eligibility 16(1)(b) Yes
2 Board Composition 17(1), 17(1A) & 17(1C), 17(1D) & 17(1E) Yes
3 Meeting Of Board Of Directors 17(2) Yes
4 Quorum of board meeting 17(2A) Yes
5 Review of Compliance Reports 17(3) Yes
6 Plans for orderly succession for appointments 17(4) Yes
7 Code of Conduct 17(5) Yes
8 Fees/compensation 17(6) Yes
9 Minimum Information 17(7) Yes
10 Compliance Certificate 17(8) Yes
11 Risk Assessment & Management 17(9) Yes
12 Performance Evaluation of Independent Directors 17(10) Yes
13 Recommendation of Board 17(11) Yes
14 Maximum number of Directorships 17A Yes
15 Composition of Audit Committee 18(1) Yes
16 Meeting of Audit Committee 18(2) Yes
17 Role of Audit Committee and information to be reviewed by the audit committee 18(3) Yes
18 Composition of nomination & remuneration committee 19(1) & (2) Yes
19 Quorum of Nomination and Remuneration Committee meeting 19(2A) Yes
20 Meeting of Nomination and Remuneration Committee 19(3A) Yes
21 Role of Nomination and Remuneration Committee 19(4) Yes
22 Composition of Stakeholder Relationship Committee 20(1), 20(2) & 20(2A) Yes
23 Meeting of Stakeholders Relationship Committee 20(3A) Yes
24 Role of Stakeholders Relationship Committee 20(4) Yes
25 Composition and role of risk management committee 21(1),(2),(3),(4) Yes
26 Meeting of Risk Management Committee 21(3A) Yes
27 Quorum of Risk Management Committee meeting 21(3B) Yes
28 Gap between the meetings of the Risk Management Committee 21(3C) Yes
29 Vigil Mechanism 22 Yes
30 Policy for related party Transaction 23(1), (1A), (5), (6), & (8) Yes
31 Prior or Omnibus approval of Audit Committee for all related party transactions 23(2), (3) Yes
32 Approval for material related party transactions 23(4) NA
33 Disclosure of related party transactions on consolidated basis 23(9) Yes
34 Composition of Board of Directors of unlisted material Subsidiary 24(1) NA
35 Other Corporate Governance requirements with respect to subsidiary of listed entity 24(2),(3),(4),(5) & (6) Yes
36 Alternate Director to Independent Director 25(1) NA
37 Maximum Tenure 25(2) Yes
38 Appointment, Re-appointment or removal of an Independent Director through special resolution or the alternate mechanism 25(2A) Yes
39 Meeting of independent directors 25(3) & (4) Yes
40 Familiarization of independent directors 25(7) Yes
41 Declaration from Independent Director 25(8) & (9) Yes
42 Directors and Officers insurance 25(10) Yes
43 Confirmation with respect to appointment of Independent Directors who resigned from the listed entity 25(11) NA
44 Memberships in Committees 26(1) Yes
45 Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel 26(3) Yes
46 Policy with respect to Obligations of directors and senior management 26(2) & 26(5) Yes
47 Approval of the Board and shareholders for compensation or profit sharing in connection with dealings in the securities of the listed entity 26(6) NA
48 Vacancies in respect Key Managerial Personnel 26A(1) & 26A(2), 26A(3) NA
Any other information to be provided - Add Notes



Annexure II
III. Affirmations
Sr Particulars Compliance status (Yes/No/NA)
1 The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been complied Yes
Any other information to be provided



Annexure II
1 Name of signatory Deepanjali Gulati
2 Designation Company Secretary and Compliance Officer



Additional Half yearly Disclosure
Any Other Information for Disclosure of Loans / Guarantees / Comfort Letters / Securities Etc.
I. Disclosure of Loans/ guarantees/comfort letters /securities etc.refer note below
(A)Any loan or any other form of debt advanced by the listed entity directly or indirectly to
Entity Aggregate amount advanced during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them
Promoter Group or any other entity controlled by them
Directors (including relatives) or any other entity controlled by them
KMPs or any other entity controlled by them
(B) Any guarantee / comfort letter (by whatever name called) provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed By
Entity Type (guarantee, comfort letter etc.) Aggregate amount of issuance during six months Balance outstanding at the end of six months(taking into account any invocation)
Promoter or any other entity controlled by them
Promoter Group or any other entity controlled by them
Directors (including relatives) or any other entity controlled by them
KMPs or any other entity controlled by them
(C) Any security provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed by
Entity Type of security (cash, shares etc.) Aggregate value of security provided during six months Balance outstanding at the end of six months
Promoter or any other entity controlled by them
Promoter Group or any other entity controlled by them
Directors (including relatives) or any other entity controlled by them
KMPs or any other entity controlled by them
(D) Additional Information
II. Affirmations
Affirmations Compliance Status Company Remarks
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company. $intratedCg.get("CG_YN_$!integratedFillingMasterDto.cgMasterVO.anx4aAffirmComplStatus")
Name
Designation
Place
Date



Signatory Details
Name of signatory Deepanjali Gulati
Designation of person Company Secretary and Compliance Officer
Place Noida
Date 28-Apr-2026


Investor Grievance Details
No. of investor complaints pending at the beginning of Quarter 3
No. of investor complaints received during the Quarter 6
No. of investor complaints disposed off during the Quarter 8
No. of investor complaints those remaining unresolved at the end of the Quarter 1


Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies-
The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below
Any Other Information for Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies 83,26,523 no. of Shares in Forum 1 Aviation Private Limited were acquired pursuant to right issue
Sr. No. Name of the unlisted company in which shares or voting rights have been acquired Date of acquisition Aggregate holding (% shares or voting rights) as at the end of the previous quarter % shares or voting rights acquired during the quarter Aggregate holding (% shares or voting rights) as at the end of the quarter
1 Remidex Pharma Private Limited 30-Mar-2026 0 100 100
2 Forum 1 Aviation Private Limited 25-Mar-2026 15.7900 0 15.7900


Disclosure of Imposition of Fine or Penalty
The details of imposition of fine or penalty during the quarter in terms of sub-para 20 of para A of Part A of Schedule III are given below:
Any Other Information for Disclosure of Imposition of Fine or Penalty
Sr. No. Name of the authority Nature and details of the action(s) taken or order(s) passed Date of receipt of direction or order, including any ad interim or interim orders, or any other communication from the authority Details of the violation(s)/ contravention(s) committed or alleged to be committed Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible


Disclosure of Updates to Ongoing Tax Litigations or Disputes
The updates on tax litigations or disputes in terms of sub-para 8 of para B of Part A of Schedule III read with corresponding provisions of Annexure 18 of the Master Circular are given below:

Any Other Information for Disclosure of Updates to Ongoing Tax Litigations or Disputes
Sr. No. Name of the opposing party Date of initiation of the litigation / dispute Status of the litigation / dispute as per last disclosure Current status of the litigation / dispute
1 Commissioner of Customs, Pune 18-Jan-2024 Custom Duty The issue pertains to Payment of differential custom duty on import of Denatured Ethyl Alcohol. We have a strong case on merits and have filed the appeal before Appellate authority contesting the order. The amount for said litigation is Basic Custom Duty Rs. 28.17 crore Fine and penalty Rs. 1.50 crore. No Change, Appeal pending with Appellate Tribunal, CESTAT, Mumbai
2 Commissioner Central Excise, Meerut 05-Mar-2020 Central Excise: Demand of 5%/8% amount on sale of excise exempted fertiliser as cenvat credit was availed on certain input services. In respect of exempted products, cenvat credit is not eligible. However, company has made the requisite reversal of ineligble cenvat credit as per Cenvat credit rules. Hence case is not maintanable. Tribunal has held the case in favour of the companyt. The company has a strong case to defend. The amount of dispute is Rs. 28.11 Crores No change, Review petition pending with Honble Allahabad High Court. Not admitted till now.
3 Commissioner of State Excise, Uttar Pradesh 21-Oct-2019 State Excise FL 39 license fee is payable for possession of denatured alcohol for use in Industry. Jubilant paid such fee for the period starting from 1981-82 till 2003-2004.�While paying the fee during the relevant period, we also approached the High court for a stay and also setting aside the fee itself.�Out of the total fee of Rs.15.21 crore paid by us for the period 1981-82 to 2003-04, Rs.8.41 crore was paid by cash and in respect of the balance amount of Rs. 6.80 crore, since High court granted stay in respect of some years, against submission of Bank Guarantee, we submitted BGs for a total amount of Rs.6.80 crore.�However, during the said period itself, we contested the said fee as no fee was payable on denatured alcohol as per several Supremecourt decisions. The Supreme court finally held hte matter in our favour and also allowed refund of the fee subject to satisfication of unjust enrichment provisions. After subsequent proceedings, the matter was remanded to Revision authority for considering the claim of the company. The company has not passed on the incidence of duty and has submitted all documentary evidences in support of its case. The company has a very strong case to defend. The amount of litigation is Rs. 15.21 crores. No change, Pending with Principal Secretary, State Excise, Government of Uttar Pradesh, Lucknow (Revision Authority)
4 State of Maharashtra 24-Jan-2012 State Excise Demand of Transport fee on rectified spirit & molasses on captive consumption. The order passed by the High court of Mumbai is in the favour of the Company and had held that no fee is payable. Govt of Maharashtra filed an SLP before the Supreme Court. The company has a very strong case to defend. The demand for said litigation is Rs. 25.70 crores. No change, Pending with Hon'ble Supreme Court
5 Income Tax Department 28-Mar-2017 Appeal filed by Demerged company (Jubilant Pharmova Limited) on different dates for FY 13 to FY 16 in relation to demerged business vested with the company (Jubilant Ingevia Limited) pursuant to NCLT order dated January 6, 2021 approving the scheme of demerger and pending before CIT (Appeals) w.r.t. notional adjustments under India Transfer Pricing Rules in relation to international transactions with Associated Enterprises - Rs.121.18 crs No Change, Ongoing and Company expects to get relief from the Appellate Authority and does not anticipate any material adverse financial implication
6 Income Tax Department 24-Aug-2022 Appeal filed by Demerged company (Jubilant Pharmova Limited) on different dates for FY 18 and FY 21 in relation to demerged business vested with the company (Jubilant Ingevia Limited) pursuant to NCLT order dated January 6, 2021 approving the scheme of demerger and pending before Income Tax Appellate Tribunal (ITAT) w.r.t. notional adjustments under India Transfer Pricing Rules in relation to international transactions with Associated Enterprises - Rs. 1.12 crs No change, Ongoing and Company expects to get relief from the Appellate Authority and does not anticipate any material adverse financial implication
7 Jubilant Pharmova Ltd. (Demerged Company) 20-Sep-2017 Appeal filed by Income tax Department against Demerged company (Jubilant Pharmova Limited) for FY 12 in relation to demerged business vested with the company (Jubilant Ingevia Limited) pursuant to NCLT order dated January 6, 2021 approving the scheme of demerger and pending before ITAT w.r.t. notional adjustments under India Transfer Pricing Rules in relation to international transactions with Associated Enterprises - Rs. 11.12 crs No Change, Ongoing and Company expects Hon'ble ITAT, Delhi to sustain the order of CIT(A) and does not anticipate any material adverse financial implication
8 Income Tax Department 12-Jul-2024 Appeal filed by Demerged company (Jubilant Pharmova Limited) for FY 17 in relation to demerged business vested with the company (Jubilant Ingevia Limited) pursuant to NCLT order dated January 6, 2021 approving the scheme of demerger and pending before Hon'ble Allahabad High Court w.r.t. notional adjustments under India Transfer Pricing Rules in relation to international transactions with Associated Enterprises - Rs. 1.86 crs No Change, Ongoing and Company expects to get relief from the Appellate Authority and does not anticipate any material adverse financial implication
9 Jubilant Pharmova Ltd. (Demerged Company) 06-Aug-2019 Appeal filed by Income tax Department against Demerged company (Jubilant Pharmova Limited) for FY 04 to FY 08 in relation to demerged business vested with the company (Jubilant Ingevia Limited) pursuant to NCLT order dated January 6, 2021 approving the scheme of demerger and pending before Allahabad High Court w.r.t. disallowance of deduction under Chapter VI-A of the Income Tax Act - Rs. 22.86 crs No change, Ongoing and Company expects Hon'ble Allahabad High Court to sustain the order of Hon'ble ITAT, Delhi and does not anticipate any material adverse financial implication